331 related articles for article (PubMed ID: 10519393)
1. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
2. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
[TBL] [Abstract][Full Text] [Related]
3. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
Braun L; Gruppuso P; Mikumo R; Fausto N
Cell Growth Differ; 1990 Mar; 1(3):103-11. PubMed ID: 1964076
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Okamoto M; Oyasu R
Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
[TBL] [Abstract][Full Text] [Related]
6. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
7. Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines.
Hsing AY; Kadomatsu K; Bonham MJ; Danielpour D
Cancer Res; 1996 Nov; 56(22):5146-9. PubMed ID: 8912849
[TBL] [Abstract][Full Text] [Related]
8. An emerging complexity of receptors for transforming growth factor-beta.
Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
[TBL] [Abstract][Full Text] [Related]
9. Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf.
Huggett AC; Hampton LL; Ford CP; Wirth PJ; Thorgeirsson SS
Cancer Res; 1990 Dec; 50(23):7468-75. PubMed ID: 2174726
[TBL] [Abstract][Full Text] [Related]
10. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
11. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
Braun L; Dürst M; Mikumo R; Gruppuso P
Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.
Danielpour D; Kadomatsu K; Anzano MA; Smith JM; Sporn MB
Cancer Res; 1994 Jul; 54(13):3413-21. PubMed ID: 8012960
[TBL] [Abstract][Full Text] [Related]
13. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells.
Danielpour D
J Cell Physiol; 1996 Jan; 166(1):231-9. PubMed ID: 8557772
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
[TBL] [Abstract][Full Text] [Related]
15. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
16. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
17. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
Valverius EM; Walker-Jones D; Bates SE; Stampfer MR; Clark R; McCormick F; Dickson RB; Lippman ME
Cancer Res; 1989 Nov; 49(22):6269-74. PubMed ID: 2553252
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 (TGF beta 1) enhances apoptosis in human papillomavirus type 16-immortalized human ectocervical epithelial cells.
Rorke EA; Jacobberger JW
Exp Cell Res; 1995 Jan; 216(1):65-72. PubMed ID: 7529191
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
Sehgal I; Baley PA; Thompson TC
Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
